{
  "docId": "019dd923-5ca1-7489-b634-d3738a63434c",
  "docSlug": "2862941a98bffda6",
  "documentTitle": "Corporate Ventures in Sweden",
  "authorId": "BCG",
  "authorName": "BCG",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.445,
  "pageNumber": 11,
  "pageCount": 28,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "industry_trends",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 15,
  "notes": "The chart uses bubble size to represent the number of companies in each industry sector.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "bubble_chart",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b634-d3738a63434c/11",
  "deckHref": "/decks/019dd923-5ca1-7489-b634-d3738a63434c",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b634-d3738a63434c.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b634-d3738a63434c#slide-11",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Pharmaceuticals and tech with highest relative share of corporate venturing among industries",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-acb6-775d-9289-a31d13623c9e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "chart",
      "text": "Bubble chart of R&D intensity vs CVC penetration",
      "attrs": null,
      "subkind": "bubble",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6606890f-a725-4227-a007-0e75f7e2b0b8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "CVC penetration: 20%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd951-acb6-775d-9289-a6a1882f505f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.04,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "1. R&D investments divided by total sales 2. Compared to global average for various industries, industry composition of leading Swedish companies implies that there should be a 32% CVC penetration 3. The actual CVC penetration of leading Swedish companies is just 20%, indicating an underperformance Source: Lovain University; BCG analysis",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "907c7cf6-1d20-4aeb-a67f-5e4e4ebc0eff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.04,
        "y": 0.1
      },
      "kind": "title",
      "text": "Pharmaceuticals and tech with highest relative share of corporate venturing among industries",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8cd41dbb-6000-4b83-81ff-3248d6486a91",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "The higher the R&D intensity the higher CVC penetration",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c4d9eaa-b92a-415e-85b5-0e785efb96ae",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [
    {
      "metricRaw": "CVC penetration",
      "numberRaw": "20%",
      "numberKind": "percent",
      "actionTitle": "The higher the R&D intensity the higher CVC penetration",
      "calloutText": "Pharmaceuticals and tech with highest relative share of corporate venturing among industries",
      "numberScale": null,
      "numberValue": 20,
      "metricFamily": "share_penetration",
      "numberCurrency": null
    }
  ],
  "tools": [
    {
      "name": "Contrast Pairs",
      "slug": "contrast-pairs",
      "agent": "Storyteller",
      "layer": "loop",
      "matchId": "019dd95a-12a5-7665-b705-cf3d4f728fdd",
      "evidence": "First page of benchmark-gap loop: actual vs aspirational lines drawn explicitly.",
      "confidence": 75
    },
    {
      "name": "Action Titles",
      "slug": "action-titles",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "019dd95a-12a5-7665-b705-c30ccaa1d709",
      "evidence": "Title 'The higher the R&D intensity the higher CVC penetration'.",
      "confidence": 88
    },
    {
      "name": "Annotation",
      "slug": "annotation",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "019dd95a-12a5-7665-b705-c614acfebd38",
      "evidence": "Each bubble labeled by industry; benchmark lines for 'Aspirational 32%' and 'Actual 20%'.",
      "confidence": 85
    },
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "019dd95a-12a5-7665-b705-cb27d8e2c8b7",
      "evidence": "Bubble chart matched to three-variable display (intensity, penetration, count).",
      "confidence": 80
    }
  ],
  "frameworks": [
    {
      "name": "Bubble Chart (R&D Intensity vs CVC Penetration)",
      "slug": null,
      "matchId": "019dd95a-1ca6-71be-9e57-3a40a5fefdb4",
      "evidence": "Two-axis chart: R&D intensity (%) × Share of companies with CVC (%); bubble size = company count.",
      "confidence": 75
    },
    {
      "name": "correlation-analysis",
      "slug": null,
      "matchId": "65542935-b36e-483a-ad48-5c8896251c4c",
      "evidence": "Bubble chart showing relationship between two variables",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 14,
      "from": 11,
      "beatId": "019dd95a-0702-74a3-87da-cab8ec6916e2",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "R&D-intensity correlation, Sweden 20% vs global 33%, Swedish CVC examples.",
      "position": 4,
      "confidence": 88,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 13,
      "from": 11,
      "name": "Benchmark Gap",
      "slug": "39-benchmark-gap",
      "bestFor": "Performance improvement, competitive analysis, target setting",
      "matchId": "019dd95a-088b-72c8-b7e2-dcf39861de57",
      "evidence": "R&D-intensity bubble chart + 'Sweden 20% vs global 33%, aspirational 32%' bars + landscape evolution.",
      "position": 4,
      "objective": "Quantify Sweden's CV underperformance vs global benchmarks",
      "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity",
      "confidence": 85,
      "description": "Compare performance against best-in-class to quantify the opportunity"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}